254 related articles for article (PubMed ID: 33117406)
1. EZH2 as a Regulator of CD8+ T Cell Fate and Function.
Stairiker CJ; Thomas GD; Salek-Ardakani S
Front Immunol; 2020; 11():593203. PubMed ID: 33117406
[TBL] [Abstract][Full Text] [Related]
2. Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8
Gray SM; Amezquita RA; Guan T; Kleinstein SH; Kaech SM
Immunity; 2017 Apr; 46(4):596-608. PubMed ID: 28410989
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of enhancer of zeste homolog 2 (EZH2) -Yin Yang 1 (YY1) axis in cancer.
Chandnani N; Gupta I; Thakkar V; Sarkar K
Pathol Res Pract; 2023 Nov; 251():154885. PubMed ID: 37862922
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
Christofides A; Karantanos T; Bardhan K; Boussiotis VA
Oncotarget; 2016 Dec; 7(51):85624-85640. PubMed ID: 27793053
[TBL] [Abstract][Full Text] [Related]
5. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
Mu W; Starmer J; Yee D; Magnuson T
Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
[TBL] [Abstract][Full Text] [Related]
6. EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production.
Guo M; Price MJ; Patterson DG; Barwick BG; Haines RR; Kania AK; Bradley JE; Randall TD; Boss JM; Scharer CD
J Immunol; 2018 Feb; 200(3):1039-1052. PubMed ID: 29288200
[TBL] [Abstract][Full Text] [Related]
7. Easy or Not-The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity.
Huang J; Zhang J; Guo Z; Li C; Tan Z; Wang J; Yang J; Xue L
Front Immunol; 2021; 12():741302. PubMed ID: 34737746
[TBL] [Abstract][Full Text] [Related]
8. Ezh2 phosphorylation state determines its capacity to maintain CD8
He S; Liu Y; Meng L; Sun H; Wang Y; Ji Y; Purushe J; Chen P; Li C; Madzo J; Issa JP; Soboloff J; Reshef R; Moore B; Gattinoni L; Zhang Y
Nat Commun; 2017 Dec; 8(1):2125. PubMed ID: 29242551
[TBL] [Abstract][Full Text] [Related]
9. Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC).
Chandnani N; Choudhari VS; Talukdar R; Rakshit S; Shanmugam G; Guchait S; Gupta I; George M; Sarkar K
Med Oncol; 2023 May; 40(7):185. PubMed ID: 37212947
[TBL] [Abstract][Full Text] [Related]
10. The Epigenetic Regulator EZH2 Instructs CD4 T Cell Response to Acute Viral Infection via Coupling of Cell Expansion and Metabolic Fitness.
Li R; Pan Z; Wu J; Yue S; Lin Y; Yang Y; Li Z; Hu L; Tang J; Shan L; Tian Q; Jiang P; Wei P; Ye L; Liu P; Chen X
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999031
[TBL] [Abstract][Full Text] [Related]
11. The noncanonical role of EZH2 in cancer.
Huang J; Gou H; Yao J; Yi K; Jin Z; Matsuoka M; Zhao T
Cancer Sci; 2021 Apr; 112(4):1376-1382. PubMed ID: 33615636
[TBL] [Abstract][Full Text] [Related]
12. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.
Wen Y; Cai J; Hou Y; Huang Z; Wang Z
Oncotarget; 2017 Jun; 8(23):37974-37990. PubMed ID: 28415635
[TBL] [Abstract][Full Text] [Related]
13. EZH2 as an Epigenetic Regulator of Cardiovascular Development and Diseases.
Yuan JL; Yin CY; Li YZ; Song S; Fang GJ; Wang QS
J Cardiovasc Pharmacol; 2021 Aug; 78(2):192-201. PubMed ID: 34029268
[TBL] [Abstract][Full Text] [Related]
14. The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2.
Ferreira M; Verbinnen I; Fardilha M; Van Eynde A; Bollen M
J Biol Chem; 2018 Nov; 293(47):18031-18039. PubMed ID: 30305391
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte expression of EZH2 is associated with mortality and secondary infectious complications in sepsis.
Zhao D; Li Z; Liu X; Liu N; Bao X; Sun H; Meng Q; Ren H; Bai J; Zhou X; Tang L
Int Immunopharmacol; 2020 Dec; 89(Pt B):107042. PubMed ID: 33068867
[TBL] [Abstract][Full Text] [Related]
16. Ezh2 Regulates Activation-Induced CD8
Chen G; Subedi K; Chakraborty S; Sharov A; Lu J; Kim J; Mi X; Wersto R; Sung MH; Weng NP
Front Immunol; 2018; 9():549. PubMed ID: 29632530
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells.
Northrop JK; Thomas RM; Wells AD; Shen H
J Immunol; 2006 Jul; 177(2):1062-9. PubMed ID: 16818762
[TBL] [Abstract][Full Text] [Related]
18. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
20. EZH2 in normal hematopoiesis and hematological malignancies.
Herviou L; Cavalli G; Cartron G; Klein B; Moreaux J
Oncotarget; 2016 Jan; 7(3):2284-96. PubMed ID: 26497210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
